Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 05:21 pm EST
Navidea Biopharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 2.26 million compared to USD 5.71 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.25 a year ago. Basic loss per share was USD 0.02 compared to USD 0.25 a year ago.
For the nine months, net income was USD 2.3 million compared to net loss of USD 11.69 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.45 a year ago. Basic earnings per share was USD 0.03 compared to basic loss per share of USD 0.45 a year ago.